EPH161 Estimation of the Size of the Eligible Population in the United States for Resmetirom: A Novel Investigational Therapy for NASH
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.989
https://www.valueinhealthjournal.com/article/S1098-3015(24)01104-5/fulltext
Title :
EPH161 Estimation of the Size of the Eligible Population in the United States for Resmetirom: A Novel Investigational Therapy for NASH
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01104-5&doi=10.1016/j.jval.2024.03.989
First page :
Section Title :
Open access? :
No
Section Order :
10427